Ionamin Articles
Antiobesity drugs to be banned in EU
6 April 2000
Antiobesity drugs to be banned in EU
31 March 2000
Medeva confident about its future
12 February 1999
Medeva Files For European Approval Of Hepagene
27 October 1998
UK's Medeva Redefining Product Portfolio
18 February 1998
Medeva Bladder Cancer Drug Filed In USA
15 January 1998
Stock Commentary Europe
6 January 1998
Medeva's Growth Dulled By "Fen-Phen" Effect
17 July 1997
Short-Term Difficulties For Medeva?
8 April 1997
Strong Growth In 1996 As Medeva Builds In the USA
24 February 1997
Medeva Takes On Single Isomer Methylphenidate
27 January 1997
UK Government Block Ban On Slimming Drugs
5 August 1996
Concerns Around Medeva Acquisition
24 June 1996
Showing 1-13 of 13 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
